VAC versus VAC+HD MPA: a randomized multinational clinical trial in postmenopausal patients with advanced breast cancer

Estevez, R. A; Robustelli, G; Pellegrini, A; Lira Puerto, V; Luchina, Alberto; Cortés Funes, H; Cazap, E; Breier, S; Machiavelli, M; Albera, C; Arraztoa, J; Silva Neto, J. E. da; Pollini, C; Zanón, P

Estevez, R. A; Robustelli, G; Pellegrini, A; Lira Puerto, V; Luchina, Alberto; Cortés Funes, H; Cazap, E; Breier, S; Machiavelli, M; Albera, C; Arraztoa, J; Silva Neto, J. E. da; Pollini, C; Zanón, P.

Rev. latinoam. oncol. clin ; 17(2): 5-17, oct. 1985. tab

Article in English | LILACS | ID: lil-27936

Subject(s)

Humans; Female; Breast Neoplasms/drug therapy; Cyclophosphamide/administration & dosage; Doxorubicin/administration & dosage; Medroxyprogesterone/administration & dosage; Neoplasm Metastasis/drug therapy; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule

Search on Google

XML

Index: LILACS (Americas) Main subject: Breast Neoplasms / Doxorubicin / Cyclophosphamide / Medroxyprogesterone / Neoplasm Metastasis Type of study: Controlled clinical trial Limits: Female / Humans Language: English Journal: Rev. latinoam. oncol. clin Journal subject: Neoplasms Year: 1985 Type: Article

Similar

MEDLINE

LILACS

LIS

Search on Google

XML